DK0536203T3 - Kombineret behandling med GnRH antagonist og GnRH til regulering af gonadotropinniveauer i pattedyr - Google Patents
Kombineret behandling med GnRH antagonist og GnRH til regulering af gonadotropinniveauer i pattedyrInfo
- Publication number
- DK0536203T3 DK0536203T3 DK91911617.8T DK91911617T DK0536203T3 DK 0536203 T3 DK0536203 T3 DK 0536203T3 DK 91911617 T DK91911617 T DK 91911617T DK 0536203 T3 DK0536203 T3 DK 0536203T3
- Authority
- DK
- Denmark
- Prior art keywords
- gnrh
- mammals
- gonadotropin
- levels
- antagonist
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 6
- 102000006771 Gonadotropins Human genes 0.000 title abstract 5
- 108010086677 Gonadotropins Proteins 0.000 title abstract 5
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 title abstract 5
- 239000002622 gonadotropin Substances 0.000 title abstract 5
- 229940121381 gonadotrophin releasing hormone (gnrh) antagonists Drugs 0.000 title abstract 2
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 title 1
- 239000002474 gonadorelin antagonist Substances 0.000 title 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 4
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 4
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 abstract 4
- 102000009151 Luteinizing Hormone Human genes 0.000 abstract 1
- 108010073521 Luteinizing Hormone Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229940094892 gonadotropins Drugs 0.000 abstract 1
- 201000010066 hyperandrogenism Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- QRYFGTULTGLGHU-NBERXCRTSA-N iturelix Chemical compound C([C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CCCCNC(=O)C=1C=NC=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)CCCNC(=O)C1=CC=CN=C1 QRYFGTULTGLGHU-NBERXCRTSA-N 0.000 abstract 1
- 108010083551 iturelix Proteins 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 229940040129 luteinizing hormone Drugs 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/538,375 US5180711A (en) | 1990-06-14 | 1990-06-14 | Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0536203T3 true DK0536203T3 (da) | 1995-04-10 |
Family
ID=24146670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91911617.8T DK0536203T3 (da) | 1990-06-14 | 1991-06-12 | Kombineret behandling med GnRH antagonist og GnRH til regulering af gonadotropinniveauer i pattedyr |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5180711A (da) |
| EP (1) | EP0536203B1 (da) |
| JP (1) | JPH05507493A (da) |
| AT (1) | ATE118171T1 (da) |
| AU (1) | AU660617B2 (da) |
| CA (1) | CA2084060C (da) |
| DE (1) | DE69107306T2 (da) |
| DK (1) | DK0536203T3 (da) |
| ES (1) | ES2067940T3 (da) |
| WO (1) | WO1991019743A2 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
| US5824286A (en) * | 1994-04-26 | 1998-10-20 | The Medical College Of Hampton Roads | Mammography method |
| US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
| US5589457A (en) * | 1995-07-03 | 1996-12-31 | Ausa International, Inc. | Process for the synchronization of ovulation |
| US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
| US6365597B1 (en) * | 1996-02-14 | 2002-04-02 | Aventis Pharmaceuticals Inc. | 4-aza steroids |
| US6455499B1 (en) | 1999-02-23 | 2002-09-24 | Indiana University Foundation | Methods for treating disorders associated with LHRH activity |
| US6703367B1 (en) | 1999-04-27 | 2004-03-09 | Praecis Pharmaceuticals Inc. | Methods for treating hot flashes and gynaecomastia |
| US6598784B2 (en) * | 2000-12-20 | 2003-07-29 | Meadwestvaco Packaging Syatens, Llc | Beverage carton with strap type carrying handle |
| PT1684782E (pt) | 2003-10-03 | 2015-12-21 | Thorn Bioscience Llc | Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio |
| US20070197435A1 (en) * | 2006-02-17 | 2007-08-23 | Webel Stephen K | Process for the synchronization of ovulation for timed breeding without heat detection |
| RU2568839C2 (ru) | 2009-04-23 | 2015-11-20 | ДжейБиЭс Юнайтид Энимал Хэлс II ЛЛК | Способ и композиция для синхронизации времени осеменения |
| DK2925339T3 (da) | 2012-11-28 | 2020-07-20 | United Ah Ii Llc | Fremgangsmåde til synkronisering af inseminationstidspunkt hos gylte |
| CN107441587A (zh) * | 2016-05-31 | 2017-12-08 | 上海微创生命科技有限公司 | 输液泵 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3583528D1 (de) * | 1984-04-03 | 1991-08-29 | Serono Lab | Verfahren zur herbeifuehrung der ovulation. |
| US4845077A (en) * | 1984-04-03 | 1989-07-04 | Serono Laboratories, Inc. | Method of inducing ovulation |
| US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
-
1990
- 1990-06-14 US US07/538,375 patent/US5180711A/en not_active Expired - Lifetime
-
1991
- 1991-06-12 DK DK91911617.8T patent/DK0536203T3/da active
- 1991-06-12 AT AT91911617T patent/ATE118171T1/de not_active IP Right Cessation
- 1991-06-12 ES ES91911617T patent/ES2067940T3/es not_active Expired - Lifetime
- 1991-06-12 DE DE69107306T patent/DE69107306T2/de not_active Expired - Fee Related
- 1991-06-12 EP EP91911617A patent/EP0536203B1/en not_active Expired - Lifetime
- 1991-06-12 JP JP91511508A patent/JPH05507493A/ja active Pending
- 1991-06-12 CA CA002084060A patent/CA2084060C/en not_active Expired - Fee Related
- 1991-06-12 WO PCT/US1991/004181 patent/WO1991019743A2/en not_active Ceased
- 1991-06-12 AU AU80616/91A patent/AU660617B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE118171T1 (de) | 1995-02-15 |
| WO1991019743A3 (en) | 1992-02-20 |
| ES2067940T3 (es) | 1995-04-01 |
| DE69107306D1 (de) | 1995-03-23 |
| EP0536203B1 (en) | 1995-02-08 |
| AU8061691A (en) | 1992-01-07 |
| EP0536203A1 (en) | 1993-04-14 |
| US5180711A (en) | 1993-01-19 |
| WO1991019743A2 (en) | 1991-12-26 |
| CA2084060A1 (en) | 1991-12-15 |
| DE69107306T2 (de) | 1995-06-08 |
| JPH05507493A (ja) | 1993-10-28 |
| CA2084060C (en) | 2000-05-16 |
| AU660617B2 (en) | 1995-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0536203T3 (da) | Kombineret behandling med GnRH antagonist og GnRH til regulering af gonadotropinniveauer i pattedyr | |
| Darendeliler et al. | Growth hormone increases rate of pubertal maturation | |
| CLEMENS et al. | Inhibition by hypothalamic prolactin implants of prolactin secretion, mammary growth and luteal function | |
| Feldberg et al. | Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy | |
| LV11782A (lv) | Lidzeklis no oinicu estrogena atkariga stavokla arstesanai | |
| ATE334674T1 (de) | Verwendung von oestrogen-agonisten oder - antagonisten zur behandlung von sexuellen funktionsstörungen | |
| KR100230720B1 (en) | Erection-inducing compositions | |
| WO2000012110A3 (en) | Use of anti(w)pressor agents for vascular remodeling in genital dysfunction | |
| DK0494264T3 (da) | Inhibering af transformede vækstfaktor til hindring af akkumulation af ekstracellulær matrix | |
| HU9004445D0 (en) | Fertility enhancement | |
| EP0796622B1 (en) | The use of a gonadotropin releasing hormone analog or mime thereof for the preparation of a pharmaceutical composition as an adjunctive for the invasive treatment of carcinomas | |
| ATE144538T1 (de) | Lhrh-antagonisten | |
| DE69912422T2 (de) | Methode zur behandlung von fruchtbarkeitsstörungen | |
| RU2000129658A (ru) | Способ терапевтического лечения бесплодия | |
| DE69935977D1 (de) | Vorbeugung und behandlung von hypergastrinemie | |
| KR930019223A (ko) | 골다공증의 치료를 위한 방법 및 조성물 | |
| GR3034743T3 (en) | Growth hormone antagonists. | |
| Bartke | Differential requirement for prolactin during pregnancy in the mouse | |
| Widmaier et al. | The interaction of estradiol and daylength in modifying serum prolactin secretion in female hamsters | |
| YU21204A (sh) | Koriscenje lh u kontrolisanoj hiperstimulaciji ovarijuma | |
| EP0788799A2 (en) | LHRH-Antagonists in the treatment of fertility disorders | |
| Uvnäs-Wallensten et al. | Inhibition of vagally induced gastrin release by somatostatin in cats | |
| Celotti et al. | Effect of prolactin on LH release in male rats | |
| ES2102397T3 (es) | Tratamiento de la enfermedad del ovario policistico. | |
| Vacher | Gn-RH agonists in the treatment of prostatic carcinoma |